
1. General Information
Bevatas 100 mg Injection contains bevacizumab, a targeted anticancer monoclonal antibody. It belongs to a class of medicines known as angiogenesis inhibitors. Bevacizumab works by blocking vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels that can supply and support tumour growth.
Bevatas 100 mg is supplied as an injectable formulation and is administered by intravenous infusion under the supervision of a qualified healthcare professional. It is generally used as part of a cancer-treatment regimen and may be combined with chemotherapy or other medicines depending on the cancer type and treatment protocol.
Phoenix Exim, based in Nagpur, India, deals in pharmaceutical products and supports international B2B requirements for medicines, subject to applicable prescription, import, export, and regulatory requirements in the destination country.
2. Product Information
Product Name: Bevatas 100 mg Injection
Active Ingredient: Bevacizumab
Strength: 100 mg/4 mL
Dosage Form: Injection / concentrate for intravenous infusion
Therapeutic Category: Anticancer / targeted therapy
Drug Class: Anti-VEGF monoclonal antibody
Manufacturer: Intas Pharmaceuticals Ltd.
Typical Storage: Refrigerated at 2°C–8°C; do not freeze.
The exact pack size, storage instructions, batch details, expiry date and other specifications should always be confirmed from the manufacturer's current product packaging and documentation.
3. Uses of Bevatas 100 mg Injection
Bevacizumab is used in combination with other anticancer treatments for several cancers. Depending on the approved indication and treatment protocol, bevacizumab may be used for:
- Metastatic colorectal cancer
- Certain types of non-small-cell lung cancer
- Kidney cancer
- Cervical cancer
- Ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
- Certain brain tumours, including recurrent glioblastoma
- Certain liver cancer treatment regimens
The precise indication, combination medicines and treatment schedule depend on the cancer type, stage, previous treatment and the applicable regulatory approval.
4. Benefits of This Medicine
When appropriately prescribed, bevacizumab may provide the following therapeutic benefits:
- Helps inhibit the formation of new blood vessels that supply tumours.
- Can slow tumour progression in appropriate cancer settings.
- May improve disease control when combined with selected chemotherapy or other anticancer medicines.
- Provides a targeted treatment approach by interfering with the VEGF pathway.
- May be incorporated into treatment protocols for several different cancer types.
The expected benefit varies significantly between patients and depends on the specific cancer and treatment combination.
5. Side Effects of Bevatas 100 mg Injection
Because bevacizumab affects blood-vessel formation and healing, it can cause potentially serious adverse reactions as well as more common side effects.
Important adverse effects can include:
- High blood pressure
- Bleeding or hemorrhage
- Delayed wound healing
- Blood clots
- Gastrointestinal perforation
- Fistula formation
- Kidney-related problems, including protein in urine
- Infusion-related reactions
- Rare but serious neurological complications
Patients should receive appropriate medical monitoring throughout treatment.
6. Common Side Effects
Depending on the treatment regimen, commonly reported effects may include:
- Weakness or fatigue
- High blood pressure
- Headache
- Nosebleeds
- Diarrhea
- Loss of appetite
- Nausea
- Mouth sores
- Joint or muscle discomfort
- Protein in the urine
Side effects can vary according to the patient's cancer, other medicines being administered and individual health status.
Seek urgent medical attention for severe bleeding, chest pain, severe abdominal pain, breathing difficulties, neurological symptoms, or other serious or unusual reactions.
7. How to Use Bevatas 100 mg Injection
Bevatas 100 mg Injection is not intended for self-administration.
It should be:
- Prescribed by an appropriate oncology specialist.
- Prepared according to the approved product instructions.
- Administered by a qualified healthcare professional.
- Given by intravenous infusion.
- Monitored during and after administration for infusion reactions and other adverse effects.
The dose and frequency are determined by the treating physician according to the cancer type, body weight, treatment regimen and clinical condition. The 100 mg vial strength does not mean that every patient should receive 100 mg as an individual treatment dose.
8. How This Medicine Works
Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF).
Tumours can stimulate the formation of new blood vessels through VEGF. These blood vessels provide oxygen and nutrients that can support tumour growth.
Bevacizumab binds to VEGF and reduces VEGF-mediated blood-vessel formation. This anti-angiogenic action can restrict the tumour's blood supply and help slow tumour progression.
9. Safety Advice for This Medicine
Bevatas 100 mg should only be used under specialist medical supervision.
Before treatment, inform your doctor if you have:
- High blood pressure
- A history of bleeding
- Blood-clotting problems
- Heart or cardiovascular problems
- Kidney problems
- A recent or planned surgical procedure
- Previous problems with wound healing
- A history of gastrointestinal perforation or fistula
- Allergies to medicines or monoclonal antibodies
- Any ongoing infection
- Pregnancy or plans to become pregnant
Because bevacizumab can interfere with wound healing, doctors may recommend withholding treatment around certain surgical procedures. Patients should not start, stop or change treatment without medical advice.
Storage: The product should generally be refrigerated at 2°C–8°C and should not be frozen, according to product information for Bevatas 100.
10. Frequently Asked Questions (FAQs)
Q1. What is Bevatas 100 mg Injection?
Bevatas 100 mg Injection is a bevacizumab-containing anticancer medicine used as part of treatment protocols for certain cancers.
Q2. What is the composition of Bevatas 100 mg?
The active ingredient is bevacizumab 100 mg, supplied as a 100 mg/4 mL presentation.
Q3. Is Bevatas 100 mg a chemotherapy medicine?
Bevacizumab is a targeted biological anticancer therapy, specifically an anti-VEGF angiogenesis inhibitor. It is frequently used together with chemotherapy or other anticancer medicines rather than functioning as conventional cytotoxic chemotherapy.
Q4. How is Bevatas 100 mg administered?
It is administered by intravenous infusion by a healthcare professional. It should not be self-administered.
Q5. What cancers can bevacizumab treat?
Depending on the applicable indication and treatment regimen, bevacizumab is used for colorectal, non-small-cell lung, kidney, cervical, ovarian/fallopian tube/peritoneal cancers and certain brain tumours, among others.
Q6. Can Bevatas 100 mg be used without a prescription?
No. It is a specialist anticancer medicine and should be used only under the supervision of an appropriately qualified healthcare professional.
Q7. How should Bevatas 100 mg be stored?
Product information for Bevatas 100 indicates refrigerated storage at 2°C–8°C and advises that it should not be frozen.
Q8. Can the dose be decided based only on the 100 mg vial?
No. The vial strength is not necessarily the patient's prescribed dose. Bevacizumab dosing depends on the specific cancer and treatment regimen and must be determined by the treating physician.
Q9. Is Bevatas 100 mg suitable for every cancer patient?
No. Suitability depends on the cancer diagnosis, treatment history, medical conditions, laboratory results and the approved indication in the relevant country.
Q10. Where can international buyers obtain product information?
For international B2B enquiries, Phoenix Exim can provide product and commercial information subject to applicable pharmaceutical export and destination-country requirements.
11. Substitutes for Bevatas 100 mg Injection
Potential alternatives containing bevacizumab include other brands or biosimilar products, depending on availability and regulatory approval in the destination market.
Examples may include:
- Avastin 100 mg/4 mL – Bevacizumab
- Other approved bevacizumab biosimilars
- Other bevacizumab brands available in individual markets
A substitute should not be selected solely on the basis of the same strength. The treating oncologist or qualified healthcare professional should confirm whether a particular brand or biosimilar is appropriate. Bevacizumab products and indications can differ according to regulatory approvals.
12. SEO Keywords
Primary Keywords
- Bevatas 100 mg Injection
- Bevatas 100 mg Injection exporter
- Bevatas 100 mg supplier India
- Bevatas 100 mg wholesaler India
- Bevacizumab 100 mg injection
- Bevacizumab 100 mg/4 mL
- Bevacizumab injection exporter from India
- Bevacizumab pharmaceutical supplier
- Bevacizumab oncology medicine supplier
- Anti cancer injection supplier India
Long-Tail B2B Keywords
- Buy Bevatas 100 mg Injection from India
- Bevatas 100 mg Injection exporter from Nagpur India
- Bevatas 100 mg Bevacizumab injection supplier India
- Bevacizumab 100 mg/4 mL injection wholesale supplier
- Bevacizumab injection pharmaceutical exporter India
- Bevatas 100 mg injection international supplier
- Bevatas 100 mg injection B2B pharmaceutical supplier
- Bevacizumab oncology injection wholesale India
- Bevacizumab 100 mg injection export supplier
- Reliable Bevacizumab injection supplier from India
- Bevatas 100 mg injection supplier for international buyers
- Bevacizumab cancer medicine exporter from Nagpur
- Bevatas 100 mg injection wholesale pharmaceutical supplier
- Bevacizumab injection supplier for hospitals and distributors
- Bevatas 100 mg injection global pharmaceutical supply
Country-Focused Keywords
- Bevatas 100 mg Injection supplier to USA
- Bevatas 100 mg Injection exporter to UK
- Bevatas 100 mg Injection supplier to Australia
- Bevatas 100 mg Injection exporter to Canada
- Bevatas 100 mg Injection supplier to Singapore
- Bevatas 100 mg Injection exporter to South Korea
- Bevatas 100 mg Injection supplier to UAE
- Bevacizumab injection exporter India to USA
- Bevacizumab injection exporter India to UK
- Bevacizumab injection supplier India to Australia
- Bevacizumab injection supplier India to Canada
- Bevacizumab injection exporter India to Singapore
- Bevacizumab injection supplier India to South Korea
- Bevacizumab injection exporter India to UAE
Phoenix Exim SEO Keywords
- Phoenix Exim Bevatas 100 mg Injection supplier
- Phoenix Exim Bevacizumab injection exporter
- Phoenix Exim pharmaceutical exporter Nagpur India
- Phoenix Exim oncology medicine supplier India
- Phoenix Exim cancer injection exporter
- Phoenix Exim Bevacizumab 100 mg supplier
- Phoenix Exim international pharmaceutical supplier
- Phoenix Exim trusted medicine exporter from India
Keywords







